Review highlights the clinical applications and cautions of proviral DNA HIV drug resistance testing for integration into care.
We review opportunities and limitations of HIV proviral resistance testing and provide practical recommendations for clinicians, laboratories, researchers, and policymakers supporting its responsible integration into care. When applied thoughtfully, it can enhance resistance assessment in selected scenarios and support care.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: